Published in Infect Immun on April 01, 2002
Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest (2008) 1.78
Lactoferrin as a natural immune modulator. Curr Pharm Des (2009) 1.40
Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res (2006) 1.18
One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect Immun (2003) 1.04
Lactoferrin--a novel bone growth factor. Clin Med Res (2005) 0.98
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin Rheumatol (2004) 0.97
Analysis of polymorphisms in the lactotransferrin gene promoter and dental caries. Int J Dent (2011) 0.91
Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response. Toxins (Basel) (2010) 0.85
Trichomoniasis and lactoferrin: future prospects. Infect Dis Obstet Gynecol (2012) 0.78
Therapeutic interventions in sepsis: current and anticipated pharmacological agents. Br J Pharmacol (2014) 0.78
Structural characterization of the interaction of human lactoferrin with calmodulin. PLoS One (2012) 0.77
Renoprotective Effect of Lactoferrin against Chromium-Induced Acute Kidney Injury in Rats: Involvement of IL-18 and IGF-1 Inhibition. PLoS One (2016) 0.77
Modulation of Interleukin-12 activity in the presence of heparin. Sci Rep (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A (1987) 10.43
Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med (1969) 5.12
The pathogenesis of sepsis. Ann Intern Med (1991) 4.34
Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol (2000) 4.32
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Chemokine receptors and their role in inflammation and infectious diseases. Blood (2000) 3.40
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07
Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 3.06
Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87
Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med (1990) 2.42
Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol (1989) 2.04
Interleukin-8 induces neutrophil transendothelial migration. Immunology (1991) 2.01
Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta (1980) 1.97
Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem (1998) 1.93
Lactoferrin is a lipid A-binding protein. Infect Immun (1994) 1.73
Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol (1993) 1.62
Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun (1993) 1.59
Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med (1999) 1.55
Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol (1993) 1.54
Primary structure of the glycans from human lactotransferrin. Eur J Biochem (1982) 1.53
Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood (2000) 1.48
Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J (1995) 1.41
Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J Biol Chem (1994) 1.32
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 1.30
Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol (1993) 1.26
Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br J Exp Pathol (1989) 1.21
N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J (1997) 1.15
The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun (1998) 1.09
Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun (2000) 1.08
The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol (1991) 1.02
Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J Leukoc Biol (1995) 1.00
A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex, and disease. J Lab Clin Med (1976) 1.00
Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation (2000) 0.97
Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch Biochem Biophys (1995) 0.96
The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem J (1997) 0.93
Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells. FEBS Lett (1995) 0.90
Characterization of human lactoferrin produced in the baculovirus expression system. Protein Expr Purif (1997) 0.90
Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin. Biochem J (1996) 0.81
Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci Biotechnol Biochem (1996) 0.79
Interaction of transferrin and its iron-binding fragments with heparin. Biochem J (1994) 0.77
Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem (2004) 1.36
Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J Immunol (2003) 1.25
Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. J Biol Chem (2004) 1.23
Lactoferrin structure and functions. Adv Exp Med Biol (2008) 1.22
Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. Glycobiology (2007) 1.21
TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet (2012) 1.20
A critical review of the roles of host lactoferrin in immunity. Biometals (2010) 1.05
Newly characterized Golgi-localized family of proteins is involved in calcium and pH homeostasis in yeast and human cells. Proc Natl Acad Sci U S A (2013) 1.02
The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. J Biol Chem (2007) 1.02
Differential effects of lobe A and lobe B of the Conserved Oligomeric Golgi complex on the stability of {beta}1,4-galactosyltransferase 1 and {alpha}2,6-sialyltransferase 1. Glycobiology (2010) 1.00
Interactions of lactoferrin with cells involved in immune function. Biochem Cell Biol (2006) 0.99
Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals (2004) 0.95
Glycosylation disorders of membrane trafficking. Glycoconj J (2012) 0.95
Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer (2005) 0.93
The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Exp Cell Res (2008) 0.93
Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism. Infect Immun (2005) 0.91
HLA-DRB1 alleles and Jk(a) immunization. Transfusion (2005) 0.91
HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol (2006) 0.91
Impact of disease-causing mutations on TMEM165 subcellular localization, a recently identified protein involved in CDG-II. Hum Mol Genet (2013) 0.90
Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate. Biochem J (2004) 0.88
Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases. Exp Cell Res (2007) 0.88
Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J Biol Chem (2010) 0.88
Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A. J Biol Chem (2012) 0.87
Ca2+ modulation of volume-regulated anion channels: evidence for colocalization with store-operated channels. FASEB J (2001) 0.86
Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression. FEBS J (2007) 0.86
Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages. J Biol Chem (2010) 0.85
Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment. Biochemistry (2005) 0.85
Mycobacterial lipomannan induces MAP kinase phosphatase-1 expression in macrophages. FEBS Lett (2008) 0.81
Expression of delta-lactoferrin induces cell cycle arrest. Biometals (2004) 0.81
Nanoscale devices for online dielectric spectroscopy of biological cells. Physiol Meas (2008) 0.81
Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging. Nanoscale (2014) 0.81
N-Glycosylation influences the structure and self-association abilities of recombinant nucleolin. FEBS J (2011) 0.81
[Lactoferrin: a multifunctional protein]. Med Sci (Paris) (2009) 0.80
Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie (2008) 0.80
Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett (2007) 0.79
Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem (2009) 0.79
PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells. J Biochem (2012) 0.77
Advances in lactoferrin research. Biochimie (2008) 0.76
Involvement of GAGs in the activity of pro-inflammatory factors. Adv Exp Med Biol (2003) 0.75